Please enable JavaScript to continue using this application.

Compare $ADPT vs $ALMR | Chartloom

Compare

$ADPT vs $ALMR

Adaptive Biotechnologies Corp · Alamar Biosciences Inc

ADPT

Adaptive Biotechnologies Corp

ALMR

Alamar Biosciences Inc

Compare $ADPT vs $ALMR

Comparing Adaptive Biotechnologies Corp and Alamar Biosciences Inc

ADPTAdaptive Biotechnologies Corp

ALMRAlamar Biosciences Inc

ADPTAdaptive Biotechnologies Corp

Market cap

$4.21B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

12.97x

Rev growth (TTM)

50.1%

YTD performance

66.5%

52W performance

70.4%

FCF yield

-0.6%

ALMRAlamar Biosciences Inc

Market cap

$1.75B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

12.35x

Rev growth (TTM)

—

YTD performance

14.9%

52W performance

14.9%

FCF yield

0.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ADPT

ALMR

Detailed metrics comparison

ADPT

Adaptive Biotechnologies Corp

ALMR

Alamar Biosciences Inc

Market Cap

ADPT$4.21B

ALMR$1.75B

Enterprise Value

ADPT$4.38B

ALMR$1.63B

Price

ADPT$26.49

ALMR$25.27

P/E Ratio

ADPTN/A

ALMRN/A

P/S Ratio

ADPT13.68x

ALMR31.58x

EV/Sales

ADPT14.21x

ALMR29.36x

EV/EBITDA

ADPT0.00x

ALMR0.00x

P/B Ratio

ADPT31.66x

ALMR7.62x

P/FCF Ratio

ADPTN/A

ALMRN/A

EV/FCF

ADPT-182.18x

ALMR0.00x

PEG Ratio

ADPTN/A

ALMRN/A

Forward P/E (NTM)

ADPTN/A

ALMRN/A

Forward P/S (NTM)

ADPT12.97x

ALMR12.35x

Revenue (TTM)

ADPT$308M

ALMR$55M

Revenue Growth (YoY)

ADPT50.1%

ALMRN/A

Forward Rev Growth

ADPT22.3%

ALMR39.6%

Gross Margin (TTM)

ADPT75.6%

ALMR58.0%

Operating Margin (TTM)

ADPT0.0%

ALMR0.0%

EBITDA Margin (TTM)

ADPT-6.7%

ALMR-45.8%

Net Margin (TTM)

ADPT-20.7%

ALMR-62.2%

FCF Margin (TTM)

ADPT-7.8%

ALMR0.0%

Net Income (TTM)

ADPT$-64M

ALMR$-35M

FCF (TTM)

ADPT$-24M

ALMR$0

EPS (TTM)

ADPT-$0.40

ALMR-$0.50

ROE (TTM)

ADPT-3264.0%

ALMR0.0%

ROA (TTM)

ADPT-1188.0%

ALMR0.0%

ROIC (TTM)

ADPT-1690.0%

ALMR0.0%

Cash

ADPT$170M

ALMR$133M

Debt

ADPT$335M

ALMR$10M

Net Cash/Debt

ADPT$-165M

ALMR$123M

Current Ratio (TTM)

ADPT4.79x

ALMR11.85x

Quick Ratio (TTM)

ADPT4.51x

ALMR9.67x

Debt/Equity (TTM)

ADPT2.34x

ALMR0.03x

Debt/Assets (TTM)

ADPT0.0%

ALMR0.0%

Interest Coverage (TTM)

ADPTN/A

ALMRN/A

Net Debt/EBITDA (TTM)

ADPT0.00x

ALMR0.00x

Beta

ADPT2.16

ALMR-0.30

52W Performance

ADPT70.4%

ALMR14.9%

YTD Performance

ADPT66.5%

ALMR14.9%

% from 52W High

ADPT-13.8%

ALMR-36.2%

% from 52W Low

ADPT120.7%

ALMR34.1%

Asset Turnover (TTM)

ADPT0.57x

ALMR0.00x

FCF Yield (TTM)

ADPT-0.6%

ALMR0.0%

Earnings Yield (TTM)

ADPT-1.5%

ALMR-2.0%

Dividend Yield (TTM)

ADPTN/A

ALMRN/A

Rule of 40

ADPT42.3

ALMR0.0

EV/GP/RG

ADPT3.28

ALMR0.30

Ticker research

View ADPT research View ALMR research

Metric	ADPT Adaptive Biotechnologies Corp	ALMR Alamar Biosciences Inc
Market & Valuation
Market Cap	$4.21B	$1.75B
Enterprise Value	$4.38B	$1.63B
Price	$26.49	$25.27
P/E Ratio	N/A	N/A
P/S Ratio	13.68x	31.58x
EV/Sales	14.21x	29.36x
EV/EBITDA	0.00x	0.00x
P/B Ratio	31.66x	7.62x
P/FCF Ratio	N/A	N/A
EV/FCF	-182.18x	0.00x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	12.97x	12.35x
Revenue & Growth
Revenue (TTM)	$308M	$55M
Revenue Growth (YoY)	50.1%	N/A
Forward Rev Growth	22.3%	39.6%
Profitability
Gross Margin (TTM)	75.6%	58.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-6.7%	-45.8%
Net Margin (TTM)	-20.7%	-62.2%
FCF Margin (TTM)	-7.8%	0.0%
Net Income (TTM)	$-64M	$-35M
FCF (TTM)	$-24M	$0
EPS (TTM)	-$0.40	-$0.50
ROE (TTM)	-3264.0%	0.0%
ROA (TTM)	-1188.0%	0.0%
ROIC (TTM)	-1690.0%	0.0%
Financial Health
Cash	$170M	$133M
Debt	$335M	$10M
Net Cash/Debt	$-165M	$123M
Current Ratio (TTM)	4.79x	11.85x
Quick Ratio (TTM)	4.51x	9.67x
Debt/Equity (TTM)	2.34x	0.03x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.16	-0.30
52W Performance	70.4%	14.9%
YTD Performance	66.5%	14.9%
% from 52W High	-13.8%	-36.2%
% from 52W Low	120.7%	34.1%
Efficiency & Yields
Asset Turnover (TTM)	0.57x	0.00x
FCF Yield (TTM)	-0.6%	0.0%
Earnings Yield (TTM)	-1.5%	-2.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	42.3	0.0
EV/GP/RG	3.28	0.30
Ticker research	View ADPT research	View ALMR research

Valuation

P/S Ratio

ADPT

13.68x

ALMR

31.58x

EV/FCF

ADPT

-182.18x

ALMR

0.00x

Growth & revenue

Revenue Growth TTM

ADPT

50.1%

Forward Revenue Growth

ALMR

39.6%

ADPT

22.3%

Profitability & performance

Gross Margin

ADPT

75.6%

ALMR

58.0%

ROE

ALMR

0.0%

ADPT

-3264.0%

FCF Yield %

ALMR

0.0%

ADPT

-0.6%

52-Week Performance

ADPT

70.4%

ALMR

14.9%

Detailed metrics comparison

ADPT

Adaptive Biotechnologies Corp

ALMR

Alamar Biosciences Inc

Market Cap

ADPT$4.21B

ALMR$1.75B

Enterprise Value

ADPT$4.38B

ALMR$1.63B

Price

ADPT$26.49

ALMR$25.27

P/E Ratio

ADPTN/A

ALMRN/A

P/S Ratio

ADPT13.68x

ALMR31.58x

EV/Sales

ADPT14.21x

ALMR29.36x

EV/EBITDA

ADPT0.00x

ALMR0.00x

P/B Ratio

ADPT31.66x

ALMR7.62x

P/FCF Ratio

ADPTN/A

ALMRN/A

EV/FCF

ADPT-182.18x

ALMR0.00x

PEG Ratio

ADPTN/A

ALMRN/A

Forward P/E (NTM)

ADPTN/A

ALMRN/A

Forward P/S (NTM)

ADPT12.97x

ALMR12.35x

Revenue (TTM)

ADPT$308M

ALMR$55M

Revenue Growth (YoY)

ADPT50.1%

ALMRN/A

Forward Rev Growth

ADPT22.3%

ALMR39.6%

Gross Margin (TTM)

ADPT75.6%

ALMR58.0%

Operating Margin (TTM)

ADPT0.0%

ALMR0.0%

EBITDA Margin (TTM)

ADPT-6.7%

ALMR-45.8%

Net Margin (TTM)

ADPT-20.7%

ALMR-62.2%

FCF Margin (TTM)

ADPT-7.8%

ALMR0.0%

Net Income (TTM)

ADPT$-64M

ALMR$-35M

FCF (TTM)

ADPT$-24M

ALMR$0

EPS (TTM)

ADPT-$0.40

ALMR-$0.50

ROE (TTM)

ADPT-3264.0%

ALMR0.0%

ROA (TTM)

ADPT-1188.0%

ALMR0.0%

ROIC (TTM)

ADPT-1690.0%

ALMR0.0%

Cash

ADPT$170M

ALMR$133M

Debt

ADPT$335M

ALMR$10M

Net Cash/Debt

ADPT$-165M

ALMR$123M

Current Ratio (TTM)

ADPT4.79x

ALMR11.85x

Quick Ratio (TTM)

ADPT4.51x

ALMR9.67x

Debt/Equity (TTM)

ADPT2.34x

ALMR0.03x

Debt/Assets (TTM)

ADPT0.0%

ALMR0.0%

Interest Coverage (TTM)

ADPTN/A

ALMRN/A

Net Debt/EBITDA (TTM)

ADPT0.00x

ALMR0.00x

Beta

ADPT2.16

ALMR-0.30

52W Performance

ADPT70.4%

ALMR14.9%

YTD Performance

ADPT66.5%

ALMR14.9%

% from 52W High

ADPT-13.8%

ALMR-36.2%

% from 52W Low

ADPT120.7%

ALMR34.1%

Asset Turnover (TTM)

ADPT0.57x

ALMR0.00x

FCF Yield (TTM)

ADPT-0.6%

ALMR0.0%

Earnings Yield (TTM)

ADPT-1.5%

ALMR-2.0%

Dividend Yield (TTM)

ADPTN/A

ALMRN/A

Rule of 40

ADPT42.3

ALMR0.0

EV/GP/RG

ADPT3.28

ALMR0.30

Ticker research

View ADPT research View ALMR research

Metric	ADPT Adaptive Biotechnologies Corp	ALMR Alamar Biosciences Inc
Market & Valuation
Market Cap	$4.21B	$1.75B
Enterprise Value	$4.38B	$1.63B
Price	$26.49	$25.27
P/E Ratio	N/A	N/A
P/S Ratio	13.68x	31.58x
EV/Sales	14.21x	29.36x
EV/EBITDA	0.00x	0.00x
P/B Ratio	31.66x	7.62x
P/FCF Ratio	N/A	N/A
EV/FCF	-182.18x	0.00x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	12.97x	12.35x
Revenue & Growth
Revenue (TTM)	$308M	$55M
Revenue Growth (YoY)	50.1%	N/A
Forward Rev Growth	22.3%	39.6%
Profitability
Gross Margin (TTM)	75.6%	58.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-6.7%	-45.8%
Net Margin (TTM)	-20.7%	-62.2%
FCF Margin (TTM)	-7.8%	0.0%
Net Income (TTM)	$-64M	$-35M
FCF (TTM)	$-24M	$0
EPS (TTM)	-$0.40	-$0.50
ROE (TTM)	-3264.0%	0.0%
ROA (TTM)	-1188.0%	0.0%
ROIC (TTM)	-1690.0%	0.0%
Financial Health
Cash	$170M	$133M
Debt	$335M	$10M
Net Cash/Debt	$-165M	$123M
Current Ratio (TTM)	4.79x	11.85x
Quick Ratio (TTM)	4.51x	9.67x
Debt/Equity (TTM)	2.34x	0.03x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.16	-0.30
52W Performance	70.4%	14.9%
YTD Performance	66.5%	14.9%
% from 52W High	-13.8%	-36.2%
% from 52W Low	120.7%	34.1%
Efficiency & Yields
Asset Turnover (TTM)	0.57x	0.00x
FCF Yield (TTM)	-0.6%	0.0%
Earnings Yield (TTM)	-1.5%	-2.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	42.3	0.0
EV/GP/RG	3.28	0.30
Ticker research	View ADPT research	View ALMR research